BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang H, Luo Y, Hu H, Yang S, Li Y, Jin H, Chen S, He Q, Hong C, Wu J, Wan Y, Li M, Li Z, Yang X, Su Y, Zhou Y, Hu B. pH-Sensitive, Cerebral Vasculature-Targeting Hydroxyethyl Starch Functionalized Nanoparticles for Improved Angiogenesis and Neurological Function Recovery in Ischemic Stroke. Adv Healthc Mater 2021;10:e2100028. [PMID: 34028998 DOI: 10.1002/adhm.202100028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu Q, Jian Z, Yang D, Zhu T. Perspective insights into hydrogels and nanomaterials for ischemic stroke. Front Cell Neurosci 2023;16. [DOI: 10.3389/fncel.2022.1058753] [Reference Citation Analysis]
2 Hughes KA, Misra B, Maghareh M, Bobbala S. Use of stimulatory responsive soft nanoparticles for intracellular drug delivery. Nano Res 2023;:1-17. [PMID: 36685637 DOI: 10.1007/s12274-022-5267-5] [Reference Citation Analysis]
3 Faria P, Pacheco C, Moura RP, Sarmento B, Martins C. Multifunctional nanomedicine strategies to manage brain diseases. Drug Deliv and Transl Res 2022. [DOI: 10.1007/s13346-022-01256-w] [Reference Citation Analysis]
4 Li Y, Wang H, Jin J, Yang C, Hu J, Li J. Advances in the research of nano delivery systems in ischemic stroke. Front Bioeng Biotechnol 2022;10:984424. [DOI: 10.3389/fbioe.2022.984424] [Reference Citation Analysis]
5 Zhuang J, Zhang X, Liu Q, Zhu M, Huang X. Targeted delivery of nanomedicines for promoting vascular regeneration in ischemic diseases. Theranostics 2022;12:6223-41. [PMID: 36168632 DOI: 10.7150/thno.73421] [Reference Citation Analysis]
6 Alonso-Alonso ML, Sampedro-Viana A, Fernández-Rodicio S, Bazarra-Barreiros M, Ouro A, Sobrino T, Campos F, Castillo J, Hervella P, Iglesias-Rey R. Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier. Int J Mol Sci 2022;23:9486. [PMID: 36012745 DOI: 10.3390/ijms23169486] [Reference Citation Analysis]
7 Liao J, Li Y, Luo Y, Meng S, Zhang C, Xiong L, Wang T, Lu Y. Recent Advances in Targeted Nanotherapies for Ischemic Stroke. Mol Pharm 2022. [PMID: 35905397 DOI: 10.1021/acs.molpharmaceut.2c00383] [Reference Citation Analysis]
8 Ding H, Tan P, Fu S, Tian X, Zhang H, Ma X, Gu Z, Luo K. Preparation and application of pH-responsive drug delivery systems. J Control Release 2022:S0168-3659(22)00327-3. [PMID: 35660634 DOI: 10.1016/j.jconrel.2022.05.056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
9 Tapeinos C, Gao H, Bauleth‐ramos T, Santos HA. Progress in Stimuli‐Responsive Biomaterials for Treating Cardiovascular and Cerebrovascular Diseases. Small. [DOI: 10.1002/smll.202200291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Zhang S, Zhou Y, Li R, Chen Z, Fan X. Advanced drug delivery system against ischemic stroke. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Xu Z, Yang D, Long T, Yuan L, Qiu S, Li D, Mu C, Ge L. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy. Carbohydr Polym 2022;277:118827. [PMID: 34893244 DOI: 10.1016/j.carbpol.2021.118827] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]